Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Dong'an road, 270, Shanghai, 200032, People's Republic of China.
Mechanical & Aerospace Engineering, University of California, 7400 Boelter Hall Los Angeles, Los Angeles, CA, 90095, USA.
Eur Radiol. 2022 Oct;32(10):6678-6690. doi: 10.1007/s00330-022-09080-z. Epub 2022 Aug 24.
Several studies have compared the efficacy of hepatic resection (HR) and thermal ablation (TA) for unresectable tumors; however, results remain inconsistent. Most cohorts in previous studies were heterogeneous groups of synchronous colorectal liver metastases (CRLM) and extrahepatic metastases. This retrospective study aimed to compare the therapeutic efficacy between TA and HR in synchronous CRLM without extrahepatic metastases.
Cases with initially synchronous CRLM without extrahepatic metastases between January 2007 and December 2018 were enrolled. Of the 448 cases, 346 received HR and 102 TA. Propensity score matching with a 1:1 ratio was used to improve the comparability between the HR and TA groups. Technical success, complications, disease-free survival (DFS), and overall survival (OS) were compared before and after matching.
All patients achieved technical success. Major complication rates in the HR and TA groups were, respectively, 36.7% and 8.8% (p < 0.001). Before matching, the 5-year OS and DFS (p = 0.004 and p = 0.020, respectively) were significantly higher in the HR group than in the TA group. After matching, no significant difference in the 5-year OS and DFS was found between the groups (p = 0.770 and p = 0.939, respectively). Local tumor progression rate was significantly higher in the TA group both before (p = 0.027) and after (p = 0.029) matching.
For patients with CRC with synchronous CRLM, TA and HR provide comparable OS and DFS. TA is preferable if complete ablation is predicted.
• Thermal ablation and hepatic resection provide comparable overall survival and disease-free survival. • Thermal ablation is a safe and effective treatment for patients with colorectal cancer with synchronous liver metastases and has a lower major complication rate and higher repeatability than hepatic resection. • Thermal ablation is preferable if complete ablation is predicted.
已有多项研究比较了不可切除肿瘤的肝切除术(HR)和热消融(TA)的疗效,但结果仍不一致。之前的大多数研究队列都是结直肠癌肝转移(CRLM)和肝外转移的同步异质性组。本回顾性研究旨在比较无肝外转移的同步 CRLM 中 TA 和 HR 的治疗效果。
纳入 2007 年 1 月至 2018 年 12 月期间最初无肝外转移的同步 CRLM 病例。在 448 例病例中,346 例行 HR,102 例行 TA。采用 1:1 比例的倾向评分匹配来提高 HR 和 TA 组之间的可比性。比较匹配前后的技术成功率、并发症、无病生存(DFS)和总生存(OS)。
所有患者均达到技术成功。HR 和 TA 组的主要并发症发生率分别为 36.7%和 8.8%(p<0.001)。匹配前,HR 组的 5 年 OS 和 DFS(p=0.004 和 p=0.020)明显高于 TA 组。匹配后,两组的 5 年 OS 和 DFS 无显著差异(p=0.770 和 p=0.939)。匹配前后,TA 组的局部肿瘤进展率均明显较高(分别为 p=0.027 和 p=0.029)。
对于 CRC 伴同步 CRLM 的患者,TA 和 HR 提供的 OS 和 DFS 相当。如果预计能达到完全消融,TA 是更好的选择。
TA 和 HR 提供的总体生存和无病生存相当。
TA 是一种安全有效的治疗方法,适用于结直肠癌伴同步肝转移患者,其主要并发症发生率较低,重复治疗率较高,优于肝切除术。
如果预计能达到完全消融,TA 是更好的选择。